Two‑year administration of sodium‑glucose co‑transporter 2 inhibitor brought about marked reduction of body fat independent of skeletal muscle amount or glycemic improvement in Japanese patients with type 2 diabetes

• Moeko Sakamoto

• Yuka Goto

• Ayako Nagayama

• Mamiko Yano

• Shuichi Sato

• Yuji Tajiri

• Masatoshi Nomura

収録刊行物

• Diabetology international / Japan Diabetes Society

  Diabetology international / Japan Diabetes Society 13 (1), 117-123, 2022

  Tokyo : Springer Japan Production Department

キーワード

• SGLT2 inhibitor
• Long-term administration
• Weight reduction
• Body fat mass
• HbA1c

詳細情報

• CRID: 1521136281246058112
• NII論文ID: 40022799856
• NII書誌ID: AA12503387
• ISSN: 21901678
• ISSN: 21901686
• DOI: 10.1007/s13340-021-00512-7
• NDL書誌ID: 031928391
• Web Site: http://id.ndl.go.jp/bib/031928391
• Web Site: https://ndlsearch.ndl.go.jp/books/R000000004-I031928391
• Web Site: https://link.springer.com/content/pdf/10.1007/s13340-021-00512-7.pdf
• Web Site: https://link.springer.com/article/10.1007/s13340-021-00512-7/fulltext.html
• Web Site: https://search.jamas.or.jp/link/ui/2023078964
• 本文言語コード: en
• NDL 雑誌分類:
  • ZS21(科学技術--医学--内科学)
• データソース種別:
  • NDL
  • Crossref
  • CiNii Articles
  • KAKEN